Unintended consequences of United States chronic pain guidelines

被引：8

作者：

Adams, Kathleen ^{[1
]}

Guerra, Michael ^{[2
]}

机构：

[1] Univ Connecticut, Dept Pharm Practice, Storrs, CT 06269 USA

[2] Yale New Haven Hosp, Dept Pharm, 20 York St, New Haven, CT 06504 USA

来源：

INTERNATIONAL JOURNAL OF CLINICAL PHARMACY | 2021年 / 43卷 / 02期

关键词：

Chronic pain; Guideline; Opioids; United States; PRESCRIBING OPIOIDS; CDC GUIDELINE;

D O I：

10.1007/s11096-020-01129-7

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

In 2015, the United States of America (USA) Department of Health and Human Services (HHS) released an issue brief that addressed opioid addiction, opioid overdoses, and opioid-related deaths as a public health concern within the country. After collaboration with state and stakeholder organizations, the HHS identified three target initiatives aimed to mitigate the negative consequences of opioid use within the USA. One initiative included implementation of guidelines to help reduce inappropriate opioid prescribing with a goal to reduce morbidity and mortality. The aim of this commentary is to discuss the misapplication and unintended consequences of the USA CDC Guideline for Prescribing Opioids for Chronic Pain.

引用

页码：313 / 317

页数：5

共 17 条

[1]

[Anonymous], 2016, CLIN EV REV CDC GUID

[2]

[Anonymous], 2019, CDC WARNS MIS ITS OP

[3]

[Anonymous], 2019, Information About Medication-Assisted Treatment (MAT)

[4]

[Anonymous], 2018, ORTHOPEDICS THIS WEE

[5] Pain Management and Opioid Regulation: Continuing Public Health Challenges [J].

Bonnie, Richard J. ;

Schumacher, Mark A. ;

Clark, J. David ;

Kesselheim, Aaron S. .

AMERICAN JOURNAL OF PUBLIC HEALTH, 2019, 109 (01) :31-34

[6]

Bradford W. David, 2017, The Relationship Between Licit Opioid Prescribing in Medicare Part D and Opioid Related Death in the U.S., 2010-2015

[7]

Connelly TP, 2020, COMPUTER PROVIDER OR

[8] Laws limiting the prescribing or dispensing of opioids for acute pain in the United States: A national systematic legal review [J].

Davis, Corey S. ;

Lieberman, Amy Judd ;

Hernandez-Delgado, Hector ;

Suba, Carli .

DRUG AND ALCOHOL DEPENDENCE, 2019, 194 :166-172

[9]

Dowell Deborah, 2016, JAMA, V315, P1624, DOI [10.15585/mmwr.rr6501e1, 10.1001/jama.2016.1464]

[10]

FDA Drug Safety Communications, 2019, FDA ID HARM REP SUDD

← 1 2 →